CoChat

Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides

Open access
Bresciani, Alberto, Ontoria, Jesus M., Biancofiore, Ilaria, Cellucci, Antonella, Ciammaichella, Alina, Di Marco, Annalise, Ferrigno, Federica, Francone, Alessandra, Malancona, Savina, Monteagudo, Edith, Nizi, Emanuela, Pace, Paola, Ponzi, Simona, Rossetti, Ilaria, Veneziano, Maria, Summa, Vincenzo, Harper, Steven · 2019 · ACS Medicinal Chemistry Letters
Cited by 32

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The application of class I HDAC inhibitors as cancer therapies is well established, but more recently their development for nononcological indications has increased. We report here on the generation of improved class I selective human HDAC inhibitors based on an ethylketone zinc binding group (ZBG) in place of the hydroxamic acid that features the majority of HDAC inhibitors. We also describe a novel set of HDAC3 isoform selective inhibitors that show stronger potency and selectivity than the most commonly used HDAC3 selective tool compound RGFP966. These compounds are again based on an alternative ZBG with respect to the ortho -anilide that is featured in HDAC3 selective compounds reported to date.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsmedchemlett.8b00517

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 32

Metadata

Authors
Bresciani, A., Ontoria, J. M., Biancofiore, I., Cellucci, A., Ciammaichella, A., Di Marco, A., Ferrigno, F., Francone, A., Malancona, S., Monteagudo, E., Nizi, E., Pace, P., Ponzi, S., Rossetti, I., Veneziano, M., Summa, V., & Harper, S.
Venue
ACS Medicinal Chemistry Letters
Published
2018-11-27
Volume
10
Issue
4
Pages
481-486
ISSN
1948-5875 (ISSN-L)
OpenAlex
W2902526624
Cited by
32
References
5
FWCI
1.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides. https://app.cochat.ai/papers/10.1021/acsmedchemlett.8b00517
The paper
Bresciani, A., Ontoria, J. M., Biancofiore, I., Cellucci, A., Ciammaichella, A., Di Marco, A., Ferrigno, F., Francone, A., Malancona, S., Monteagudo, E., Nizi, E., Pace, P., Ponzi, S., Rossetti, I., Veneziano, M., Summa, V., & Harper, S. (2019). Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides. ACS Medicinal Chemistry Letters. https://doi.org/10.1021/acsmedchemlett.8b00517

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.